Biosplice Therapeutics Alternatives & Competitors
12 companies similar to Biosplice Therapeutics — Restore health by delivering first-in-class therapies that harness alternative s...
Companies similar to Biosplice Therapeutics
CK Regeon
CK Regeon Inc. is a biotechnology-based company aiming to develop First-In-Class drugs wit...
Surrozen
Surrozen is a biotechnology company focused on discovering and developing novel regenerati...
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
AgeX Therapeutics, Inc.
AgeX Therapeutics is focused on the development and commercialization of novel therapeutic...
Rival Readout
Competing with Biosplice Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Notogen Inc.
Developing a disease-modifying regenerative therapy for degenerative disc disease
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve th...
ProteoTech
Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
PIC Therapeutics
Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes
About Biosplice Therapeutics
Biosplice Therapeutics, founded in 2008 and headquartered in the United States, is dedicated to restoring health by delivering pioneering therapies that leverage alternative splicing. The company's focus on small-molecule therapeutics, rooted in the groundbreaking science of alternative pre-mRNA splicing, has led to th...
Therapeutic Modulation of Alternative Splicing
Patients with Osteoarthritis, Cancer, Neurological Disorders, and Diabetes
Medical Research, Therapeutics Development, Regenerative Medicine, Oncology, Degenerative Diseases, Alternative Splicing, Wnt Pathway Modulation, Small Molecule Therapeutics, Clinical Development, Tissue-Level Regeneration, Alzheimer's Disease, Pre-mRNA Splicing, CLK/DYRK Kinases, Regenerative Pathways
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Biosplice Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Biosplice Therapeutics on 24 Mar 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.